Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment
Crossref DOI link: https://doi.org/10.1186/s12890-016-0268-3
Published Online: 2016-07-26
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Izumo, Takehiro
Matsumoto, Yuji
Chavez, Christine
Tsuchida, Takaaki
Funding for this research was provided by:
The National Cancer Center Research and Development Fund (28-K-1)
License valid from 2016-07-26